IP Library Assignment 070887/0702
Patent Assignment
Reel/Frame 070887/0702

Corrective Assignment to Correct the Application Number Previously Recorded at Reel: 67245 Frame: 714. Assignor(S) Hereby Confirms the Assignment.

Recorded: 2025-04-17 Pages: 29
Assignor
PALADIN PHARMA INC.
Executed: 2024-04-24
Assignee
ENDO OPERATIONS LIMITED
FIRST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD, BALLSBRIDGE, 4, IRELAND
Covered Properties (22)
Process for the Preparation of Amphiphilic Poly (N-Vinyl-2-Pyrrolidone) Block Copolymers
Patent: 7,262,253 →
Application: 10/727,083 →
Publication: US 2005/0119404
Controlled-release compositions
Patent: 8,487,002 →
Application: 11/111,996 →
Publication: US 2006/0240107
Sustained-Release Tramadol Formulations with 24-Hour Efficacy
Patent: 7,988,998 →
Application: 11/112,008 →
Publication: US 2007/0003618
Ultrapure 4-Methylpyrazole
Patent: 7,553,863 →
Application: 11/279,708 →
Publication: US 2007/0244330
Bilayer Composition for the Sustained Release of Acetaminophen and Tramadol
Patent: 8,895,066 →
Application: 12/252,117 →
Publication: US 2009/0130183
Misuse Preventative, Controlled Release Formulation
Patent: 8,486,448 →
Application: 12/336,495 →
Publication: US 2009/0175937
Misuse Preventative, Controlled Release Formulation
Patent: 8,486,449 →
Application: 12/639,664 →
Publication: US 2010/0239662
Oligonucleotide Duplexes Comprising Dna-Like and Rna-Like Nucleotides and Uses Thereof
Patent: 9,090,649 →
Application: 12/996,362 →
Publication: US 2011/0077286
Narcotic Drug Formulations with Decreased Abuse Potential
Patent: 8,460,640 →
Application: 13/133,141 →
Publication: US 2011/0237615
Misuse Preventative, Controlled Release Formulation
Patent: 8,691,270 →
Application: 13/919,476 →
Publication: US 2013/0344142
Misuse Preventative, Controlled Release Formulation
Patent: 8,685,447 →
Application: 13/919,499 →
Publication: US 2014/0004191
Misuse Preventative, Controlled Release Formulation
Patent: 8,920,833 →
Application: 14/195,813 →
Publication: US 2014/0193494
Misuse Preventative, Controlled Release Formulation
Patent: 8,927,013 →
Application: 14/195,833 →
Publication: US 2014/0248346
Misuse Preventative, Controlled Release Formulation
Patent: 8,920,834 →
Application: 14/305,895 →
Publication: US 2014/0294954
Misuse Preventative, Controlled Release Formulation
Patent: 8,927,014 →
Application: 14/305,935 →
Publication: US 2014/0294955
Oligonucleotide Duplexes Comprising Dna-Like and Rna-Like Nucleotides and Uses Thereof
Patent: 9,719,091 →
Application: 14/810,148 →
Publication: US 2016/0145613
Solid Formulations of Liquid Biologically Active Agents
Application: 15/817,907 →
Publication: US 2018/0140706
Injection Techniques for the Treatment of Cellulite
Application: 17/259,784 →
Publication: US 2021/0187084
Compositions and Methods for Treating Cellulite
Application: 17/276,507 →
Publication: US 2024/0277595
Collagenase Formulations and Methods of Producing the Same
Application: 17/419,899 →
Publication: US 2022/0305094
Methods of Reducing Collagenase-Mediated Bruising in a Subject Having Cellulite
Application: 18/315,351 →
Publication: US 2023/0405097
Method of Treating or Reducing Efp
Application: 18/415,270 →
Publication: US 2024/0216485
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 13, 2017
From: THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY
To: LABOPHARM INC.
Reel/Frame 041559/0271 →
Assignment of Assignor's Interest Mar 13, 2017
From: DAMHA, MASAD J.; WATTS, JONATHAN K.; DELEAVEY, GLEN
To: THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY
Reel/Frame 041559/0222 →
Change of Name Mar 13, 2017
From: CHIMIGEN INC.
To: LABOPHARM INC.
Reel/Frame 041559/0361 →
Assignment of Assignor's Interest Mar 13, 2017
From: LABOPHARM INC.
To: CHIMIGEN INC.
Reel/Frame 041559/0307 →
Assignment of Assignor's Interest Mar 13, 2017
From: THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY
To: LABOPHARM INC.
Reel/Frame 041559/0289 →
Change of Name Apr 8, 2020
From: LABOPHARM (BARBADOS) LIMITED
To: PALADIN LABS (BARBADOS) INC.
Reel/Frame 052348/0218 →
Change of Name Apr 8, 2020
From: CHIMIGEN INC.
To: LABOPHARM INC.
Reel/Frame 052348/0178 →
Assignment of Assignor's Interest Apr 8, 2020
From: LABOPHARM INC.
To: CHIMIGEN INC.
Reel/Frame 052348/0172 →
Assignment of Assignor's Interest Apr 8, 2020
From: LUO, LAIBIN; RAVENELLE, FRANCOIS; GORI, SANDRA; LESSARD, DAVID
To: LABOPHARM INC.; LABOPHARM EUROPE LIMITED; LABOPHARM (BARBADOS) LIMITED
Reel/Frame 052348/0073 →
Assignment of Assignor's Interest Apr 8, 2020
From: RAVENELLE, FRANCOIS; GORI, SANDRA; LESSARD, DAVID; LUO, LAIBIN
To: LABOPHARM INC.; LABOPHARM EUROPE LIMITED; LABOPHARM (BARBADOS) LIMITED
Reel/Frame 052348/0118 →
Change of Address Apr 8, 2020
From: LABOPHARM (BARBADOS) LIMITED
To: LABOPHARM (BARBADOS) LIMITED
Reel/Frame 052351/0048 →
Merger Apr 8, 2020
From: PALADIN LABS (BARBADOS) INC. (COMPANY #30304); LABOPHARM (BARBADOS) LIMITED (COMPANY # 21899)
To: LABOPHARM (BARBADOS) LIMITED (COMPANY # 36646)
Reel/Frame 052350/0943 →
Change of Name Apr 8, 2020
From: LABOPHARM EUROPE LIMITED
To: PALADIN LABS EUROPE LIMITED
Reel/Frame 052348/0240 →
Merger Apr 8, 2020
From: LABOPHARM INC.
To: PALADIN LABS INC.
Reel/Frame 052348/0223 →
Confirmatory Grant of Security Interest in United States Patents May 26, 2020
From: ENDO GLOBAL VENTURES; ENDO VENTURES LIMITED; PALADIN LABS INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 053548/0239 →
Confirmatory Grant of Security Interest in United States Patents Apr 6, 2021
From: ENDO GLOBAL VENTURES; PALADIN LABS INC.; ENDO VENTURES LIMITED
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055845/0170 →
Confirmatory Grant of Security Interest in United States Patents Apr 6, 2021
From: ENDO GLOBAL VENTURES; PALADIN LABS INC.; ENDO VENTURES LIMITED
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055845/0162 →
Assignment of Assignor's Interest May 6, 2021
From: PALADIN LABS (BARBADOS) INC.
To: ENDO VENTURES LIMITED
Reel/Frame 056168/0284 →
Confirmatory Grant of Security Interest in United States Patents Sep 17, 2021
From: ENDO VENTURES LIMITED; ENDO GLOBAL VENTURES; PALADIN LABS INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0893 →
Assignment of Assignor's Interest Mar 5, 2024
From: ENDO VENTURES UNLIMITED COMPANY
To: OPERAND PHARMACEUTICALS III LIMITED
Reel/Frame 066732/0137 →
Change of Name Mar 5, 2024
From: OPERAND PHARMACEUTICALS III LIMITED
To: ENDO OPERATIONS LIMITED
Reel/Frame 066732/0413 →
Change of Name Mar 5, 2024
From: ENDO VENTURES LIMITED
To: ENDO VENTURES UNLIMITED COMPANY
Reel/Frame 066732/0396 →
Assignment of Assignor's Interest Apr 23, 2024
From: PALADIN LABS INC.
To: PALADIN PHARMA INC.
Reel/Frame 067203/0281 →
Release of Security Interest Apr 24, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ENDO GLOBAL AESTHETICS LIMITED; ENDO GLOBAL VENTURES; ENDO VENTURES BERMUDA LIMITED; ENDO VENTURES LIMITED
Reel/Frame 067216/0376 →
Release of Security Interest Apr 24, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ENDO GLOBAL AESTHETICS LIMITED; ENDO GLOBAL VENTURES; ENDO VENTURES BERMUDA LIMITED; ENDO VENTURES LIMITED
Reel/Frame 067216/0390 →